Modeling of diarylalkyl-imidazole and diarylalkyl-triazole derivatives as potent aromatase inhibitors for treatment of hormone-dependent cancer

Copyright 2010 Wiley Periodicals, Inc.

Bibliographische Detailangaben
Veröffentlicht in:Journal of computational chemistry. - 1984. - 31(2010), 12 vom: 25. Sept., Seite 2342-53
1. Verfasser: Nagar, Shuchi (VerfasserIn)
Weitere Verfasser: Saha, Achintya
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2010
Zugriff auf das übergeordnete Werk:Journal of computational chemistry
Schlagworte:Journal Article Research Support, Non-U.S. Gov't Antineoplastic Agents, Hormonal Aromatase Inhibitors Imidazoles Ligands Triazoles Hydrogen 7YNJ3PO35Z
LEADER 01000naa a22002652 4500
001 NLM196855489
003 DE-627
005 20231223205401.0
007 cr uuu---uuuuu
008 231223s2010 xx |||||o 00| ||eng c
024 7 |a 10.1002/jcc.21528  |2 doi 
028 5 2 |a pubmed24n0656.xml 
035 |a (DE-627)NLM196855489 
035 |a (NLM)20340106 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Nagar, Shuchi  |e verfasserin  |4 aut 
245 1 0 |a Modeling of diarylalkyl-imidazole and diarylalkyl-triazole derivatives as potent aromatase inhibitors for treatment of hormone-dependent cancer 
264 1 |c 2010 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 19.10.2010 
500 |a Date Revised 21.11.2013 
500 |a published: Print 
500 |a Citation Status MEDLINE 
520 |a Copyright 2010 Wiley Periodicals, Inc. 
520 |a Aromatase is an enzyme that catalyzes the final step in the conversion of androgen to estrogen. It has become an attractive target for the treatment of estrogen responsive breast cancer. The study has been focused on designing aromatase inhibitors (AIs) that can be selected as probable drug candidate for the treatment of breast cancer. In the present study, long chain diarylalkyl-imidazole and -triazole scaffolds have been considered for exploring pharmacophores as potent AIs using QSAR (Quantitative SAR) and pharmacophore mapping studies. The model generated in linear free energy QSAR study (R(2) = 0.905, Q(2)= 0.885, R(2)(pred(ts)) = 0.763) showed the importance of hydrophobicity, size and shape of the molecule, van der Waals surface and hydrogen atom contribution influence the activity. 3D QSAR of comparative molecular field analysis (CoMFA, R(2)= 0.921, Q(2) = 0.741, R(2)(pred(ts))= 0.583) showed that steric and electrostatic features along with hydrophobicity and electronic charge contribution at C(4) (Fig. 1) influence on the inhibitory activity. Comparative molecular similarity analysis (CoMSIA, R(2) = 0.874, Q(2) = 0.716, R(2)(pred(ts)) = 0.591) study adjudged the presence of steric, electrostatic and hydrophobic fields together with hydrogen bond (HB) donor and acceptor play significant role in inhibitory activity to aromatase enzyme. Further pharmacophore mapping study (Q(2) = 0.947, Delta(cost) = 113.171, R(2)(pred(ts)) = 0.857) suggested that presence of HB acceptor, hydrophobicity with aromatic ring, and the importance of steric contribution influence on the activity. The critical distances among the features are also important for the inhibitor activity 
650 4 |a Journal Article 
650 4 |a Research Support, Non-U.S. Gov't 
650 7 |a Antineoplastic Agents, Hormonal  |2 NLM 
650 7 |a Aromatase Inhibitors  |2 NLM 
650 7 |a Imidazoles  |2 NLM 
650 7 |a Ligands  |2 NLM 
650 7 |a Triazoles  |2 NLM 
650 7 |a Hydrogen  |2 NLM 
650 7 |a 7YNJ3PO35Z  |2 NLM 
700 1 |a Saha, Achintya  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Journal of computational chemistry  |d 1984  |g 31(2010), 12 vom: 25. Sept., Seite 2342-53  |w (DE-627)NLM098138448  |x 1096-987X  |7 nnns 
773 1 8 |g volume:31  |g year:2010  |g number:12  |g day:25  |g month:09  |g pages:2342-53 
856 4 0 |u http://dx.doi.org/10.1002/jcc.21528  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 31  |j 2010  |e 12  |b 25  |c 09  |h 2342-53